Quick Answer
Galera Therapeutics, Inc. reported Total Assets of $7.20 million for fiscal year 2025.
Galera Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $7.20M | -28.8% |
| 2024 | $10.10M | -61.4% |
| 2023 | $26.14M | -40.6% |
| 2022 | $44.04M | -47.1% |
| 2021 | $83.31M | -0.9% |
| 2020 | $84.10M | -31.8% |
| 2019 | $123.38M | +40.1% |
| 2018 | $88.06M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.00M | -43.8% | -17.3% |
| June 30, 2025 | $6.05M | -63.1% | -21.1% |
| March 31, 2025 | $7.66M | -61.0% | -24.2% |
| December 31, 2024 | $10.10M | -61.4% | +13.5% |
| September 30, 2024 | $8.90M | -76.4% | -45.7% |
| June 30, 2024 | $16.38M | -66.1% | -16.6% |
| March 31, 2024 | $19.65M | -67.1% | -24.8% |
| December 31, 2023 | $26.14M | -40.6% | -30.8% |
- Galera Therapeutics, Inc. showed a decrease of -28.8% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Galera Therapeutics, Inc.’s total assets has declined by 91.8% (from $88.06 million to $7.20 million).
- The most recent figure is from Galera Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: